Tempus AI, Inc. (NASDAQ:TEM) Short Interest Up 22.2% in November

Tempus AI, Inc. (NASDAQ:TEM) was the target of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 5,110,000 shares, an increase of 22.2% from the November 15th total of 4,180,000 shares. Based on an average daily volume of 1,260,000 shares, the short-interest ratio is presently 4.1 days. Currently, 10.3% of the shares of the company are sold short.

Tempus AI Price Performance

Shares of TEM traded down $0.99 during midday trading on Friday, reaching $41.00. The stock had a trading volume of 5,058,569 shares, compared to its average volume of 1,427,998. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business has a 50-day moving average price of $52.64. Tempus AI has a 12-month low of $22.89 and a 12-month high of $79.49.

Insider Buying and Selling at Tempus AI

In related news, CFO James William Rogers sold 83,025 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.30, for a total value of $3,511,957.50. Following the completion of the transaction, the chief financial officer now directly owns 231,280 shares of the company’s stock, valued at approximately $9,783,144. This trade represents a 26.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Ryan Fukushima sold 120,000 shares of the firm’s stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.51, for a total value of $5,101,200.00. Following the completion of the transaction, the chief operating officer now directly owns 1,007,207 shares of the company’s stock, valued at $42,816,369.57. The trade was a 10.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 650,949 shares of company stock valued at $27,821,944.

Institutional Trading of Tempus AI

Hedge funds have recently bought and sold shares of the company. Franklin Resources Inc. lifted its stake in Tempus AI by 1.0% in the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after purchasing an additional 8,387 shares during the last quarter. Tidal Investments LLC purchased a new position in shares of Tempus AI in the third quarter worth about $7,633,000. Teachers Retirement System of The State of Kentucky lifted its stake in shares of Tempus AI by 6.3% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock valued at $7,160,000 after acquiring an additional 7,500 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after acquiring an additional 539 shares during the period. Finally, XTX Topco Ltd bought a new position in Tempus AI during the 3rd quarter worth approximately $502,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on TEM shares. Loop Capital boosted their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Finally, Bank of America upped their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $56.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.